Related Topics
New online trackers follow COVID-19 vaccine rollouts in U.S., India
New online trackers developed by Harvard’s Geographic Insights lab provide daily updates and geographic visualizations of the COVID-19 vaccine rollout in the U.S. and in India.
Why focusing on public health is good for the economy
Investing in public health is crucial both for keeping people healthy and for maintaining a strong economy, according to Harvard Chan School Dean Michelle Williams.
Exploring how ‘forever chemicals’ may harm immune function
Mounting evidence suggests that widely used chemicals called per- and polyfluoroalkyl substances (PFASs) interfere with immune system function. Experts are concerned that exposure to these chemicals could diminish the immune system’s ability to fight a host of infectious…
Can herd immunity stop COVID-19?
Whether or not COVID-19 can be conquered through herd immunity is an open question, according to experts.
Support for a national vaccine holiday grows
A group of public health experts including Harvard T.H. Chan School of Public Health doctoral student Keona Wynne are pushing for the creation of a National Vaccine Day, a one-time federal holiday to build confidence in vaccines and…
Where we stand with the pandemic, one year in
In a Vanity Fair podcast, William Hanage discussed COVID-19 vaccines, variants, CDC guidelines, and what he's learned during the pandemic.
Mary Bassett talks vaccine confidence with Harlem fashion icon ‘Dapper Dan’
A new Vogue magazine video features Harlem-based fashion designer Daniel “Dapper Dan” Day and Harvard Chan School’s Mary Bassett discussing the importance of getting COVID-19 vaccines.
HPV vaccines for adults over age 26 may not be cost-effective
For immediate release: Thursday, March 11, 2021 Boston, MA – Vaccinating adults age 26 and older against the human papillomavirus (HPV)—the virus that causes more than 90% of cervical cancers as well as several other cancers—may not be…
Perspective: Convincing a skeptical public to accept COVID-19 vaccines
Recent polling suggests that many Americans are undecided about getting a COVID-19 vaccine, but the polls also offers insights about how to encourage greater acceptance of vaccines, according to experts from Harvard Chan School.
A Shot in the Arm
Vaccines are underfunded, understudied, and underappreciated as a vital tool in public health. could COVID-19 be the start of a vaccine renaissance?